Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.39 |
| ▸ | NPC1 | O15118 | 5/20 | 0.39 |
| ▸ | RAB9A | P51151 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7991192 | 0.98 | CXCR3 (0.42) | ALDH1A1ALOX15PKMCXCR3SMN1; SMN2 | |
| SCHEMBL7994833 | 0.93 | — | — | |
| SCHEMBL4635955 | 0.83 | ALDH1A1 (0.40) | ALDH1A1ALOX15PKMCXCR3SMN1; SMN2 | |
| SCHEMBL722436 | 0.83 | ALDH1A1 (0.44) | ALDH1A1ALOX15PKMSMN1; SMN2NPC1 | |
| SCHEMBL27927911 | 0.81 | ALDH1A1 (0.39) | ALDH1A1ALOX15PKMCXCR3SMN1; SMN2 | |
| SCHEMBL6165925 | 0.77 | ALDH1A1 (0.45) | ALDH1A1ALOX15SMN1; SMN2NPC1RAB9A | |
| SCHEMBL7776189 | 0.77 | ALDH1A1 (0.40) | ALDH1A1ALOX15SMN1; SMN2NPC1RAB9A | |
| SCHEMBL24784 | 0.77 | ALDH1A1 (0.36) | ALDH1A1ALOX15PKMCXCR3SMN1; SMN2 | |
| SCHEMBL30603 | 0.77 | ALDH1A1 (0.36) | ALDH1A1ALOX15PKMCXCR3SMN1; SMN2 | |
| SCHEMBL3647069 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115340504-B | Fluorene group-containing compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-2288340-B1 | NANOPARTICLE FORMULATIONS AND USES THEREOF | ABRAXIS BIOSCIENCE LLC (US) | 2020-06-24 | — | — | EP | disclosed |
| EP-2416650-B1 | NANOPARTICLE FORMULATIONS AND USES THEROF | ABRAXIS BIOSCIENCE LLC (US) | 2020-02-26 | — | — | EP | disclosed |
| US-10570431-B2 | Compositions comprising a polypeptide having cellulolytic enhancing activity and a heterocyclic compound and uses thereof | NOVOZYMES, INC. (US) | 2020-02-25 | — | — | US | disclosed |
| US-20180363018-A1 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Heterocyclic Compound And Uses Thereof | NOVOZYMES, INC. (US) | 2018-12-20 | — | — | US | disclosed |
| US-20180289620-A1 | NANOPARTICLE FORMULATIONS AND USES THEREOF | ABRAXIS BIOSCIENCE, LLC | 2018-10-11 | — | — | US | disclosed |
| US-10087478-B2 | Compositions comprising a polypeptide having cellulolytic enhancing activity and a nitrogen-containing compound and uses thereof | NOVOZYMES, INC. (US) | 2018-10-02 | — | — | US | disclosed |
| US-10041101-B2 | Compositions comprising a polypeptide having cellulolytic enhancing activity and a heterocyclic compound and uses thereof | NOVOZYMES, INC. (US) | 2018-08-07 | — | — | US | disclosed |
| EP-2603594-B1 | COMPOSITIONS COMPRISING A POLYPEPTIDE HAVING CELLULOLYTIC ENHANCING ACTIVITY AND A BICYCLIC COMPOUND AND USES THEREOF | NOVOZYMES INC (US) | 2018-04-25 | — | — | EP | disclosed |
| EP-2603598-B1 | COMPOSITIONS COMPRISING A GH61 POLYPEPTIDE HAVING CELLULOLYTIC ENHANCING ACTIVITY AND A QUINONE COMPOUND AND USES THEREOF | NOVOZYMES INC (US) | 2018-04-18 | — | — | EP | disclosed |
| WO-2009126938-A1 | NANOPARTICLE FORMULATIONS AND USES THEREOF | ABRAXIS BIOSCIENCES, LLC (US) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009126401-A1 | COMPOSITIONS OF HYDROPHOBIC TAXANE DERIVATIVES AND USES THEREOF | ABRAXIS BIOSCIENCE, LLC (US) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009115572-A2 | NOVEL HETEROCYCLIC COMPOUNDS AND USES THEROF | NOVARTIS AG (CH) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009042694-A1 | (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING | COMENTIS, INC. (US) | 2009-04-02 | — | — | WO | disclosed |
| WO-2008155727-A1 | PLATINUM (IV) COMPLEXES | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2008-12-24 | — | — | WO | disclosed |
| CN-101145514-A | Method of forming fine pattern of semiconductor device | HYNIX SEMICONDUCTOR INC (KR) | 2008-03-19 | — | — | CN | disclosed |
| CN-101145515-A | Method for forming a fine pattern of a semiconductor device | HYNIX SEMICONDUCTOR INC (KR) | 2008-03-19 | — | — | CN | disclosed |
| US-6277790-B1 | APPLYING PLANTS, SEEDS, SOILS OR ENVIRONMENT | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-21 | — | — | US | disclosed |
| EP-1003741-A1 | SUBSTITUTED HERBICIDE TETRAZOLINONECARBOXYLIC ACID AMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-31 | — | — | EP | disclosed |
| WO-1999007702-A1 | SUBSTITUTED HERBICIDE TETRAZOLINONECARBOXYLIC ACID AMIDES | BASF AKTIENGESELLSCHAFT (DE) | 1999-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180289620-A1 | NANOPARTICLE FORMULATIONS AND USES THEREOF | ABCB1, SLC47A1, ABCC1 | ALDH1A1 1501/4885ALOX15 3586/4885PKM 3884/4885 |
| US-10570431-B2 | Compositions comprising a polypeptide having cellulolytic enhancing activity and a heterocyclic compound and uses thereof | CEL, VIP, CTRC | ALDH1A1 4339/4885ALOX15 738/4885PKM 1703/4885 |
| US-20180363018-A1 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Heterocyclic Compound And Uses Thereof | CEL, VIP, CTRC | ALDH1A1 4339/4885ALOX15 738/4885PKM 1703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.